G. Hajak,

Göran Hajak is Professor of Psychiatry at the University of Regensburg. Dr. Hajak also holds clinical and administrative positions as Director of the Department of Psychiatry, Psychosomatic Medicine and Psychotherapy and as Deputy Medical Director of the Social Foundation Bamberg, a maximum care hospital network with 32 clinical departments and teaching hospital of the University of Erlangen, Germany. He has been Medical Board Certified for Neurology, Psychiatry, Psychotherapy, Sleep Medicine, and Traffic Medicine, and has received a Master of Business Administration degree in Health Management*. Dr. Hajak´s widespread scientific interests are reflected in his author- and co-authorship of in total 1400 publications, including 387 peer-reviewed original papers and 210 review articles with an accumulated impact factor of 1343, 131 book chapters, 22 books, and more than 800 abstracts (Jan-uary 2021) covering the areas of affective, emotional, psychotic, somatoform, cognitive and sleep disorders, the mechanisms of neuroplasticity and brain networking, psychopharmacology, and health management. His work has qualified him to be named in the Who-is-Who-List of Medi-cine Germany and the Focus TOP-100-Best-List of Medical Doctors in Germany as a distinguished physician for the treatment of Depression, Bipolar Disorders, Schizophrenia, Anxiety Disorders, and Sleep Disorders.

Moderator of 1 Session

Industry Session
Date
Mon, 12.04.2021
Session Time
14:15 - 14:45
Room
Industry 2
Chair(s)
Session Description
Cariprazine from the clinical perspective: new clues in the treatment of schizophrenia - SUPPORTED BY Richter-Recordati

Session Description:

The product theatre aims to provide further understanding of the effectiveness and safety of cariprazine, a novel D3-D2 partial dopamine agonist. While novel medications are the driving force of improved treatment and eventually better life for patients, there is in general a bit of fear of trying out new drugs. To alleviate these fears, professor Göran Hajak will provide some insight in how to use cariprazine in the clinic, explain the rationale behind the clinical decisions to prescribe cariprazine and bring a few cases to illustrate the process.

Session Icon
Product Theatre

Presenter of 1 Presentation

Product Theatre not Included in the Main Event CME / CPD Credit (ID 1152) No Topic Needed

Cariprazine from the clinical perspective: new clues in the treatment of schizophrenia

Session Icon
Product Theatre
Date
Mon, 12.04.2021
Session Time
14:15 - 14:45
Room
Industry 2
Lecture Time
14:15 - 14:45
Presenter